Phase 2 Clinical Trials
Phase 2 trials test whether a treatment works for a specific condition. Larger groups (100-300) receive the treatment while researchers monitor effectiveness and side effects.
About Phase 2
Phase 2 trials evaluate whether a treatment is effective for a particular disease or condition. The treatment has already passed Phase 1 safety testing. Researchers also continue to study safety and determine optimal dosing.
Top Conditions
Top Sponsors
Frequently Asked Questions
Phase 2 trials evaluate whether a treatment is effective for a particular disease or condition. The treatment has already passed Phase 1 safety testing. Researchers also continue to study safety and determine optimal dosing.
There are currently 2,178 Phase 2 clinical trials tracked in our database. These trials span multiple conditions and are run by a mix of pharmaceutical companies, academic institutions, and government agencies.
The conditions with the most Phase 2 trials include Liver Cancer (34 trials), Lymphoma (31 trials), Multiple Myeloma (30 trials), Stomach Cancer (29 trials), Sarcoma (27 trials).
To participate in a Phase 2 trial, browse the conditions below to find relevant trials, review the eligibility criteria, and talk to your doctor about whether participation is appropriate for your situation.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.
Source: ClinicalTrials.gov, 2026.